微质组素H3K18的克罗托尼化促进STAT1的表达,并诱导阿尔茨海默病的认知缺陷

相关实验视频

Updated: Feb 13, 2026

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

44.6K

Ying Weng^1,2, Ting He^1,2, Mengzhu Li^1,2

¹Department of Pathophysiology, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in immunology

|February 12, 2026

概括

微质细胞中升高的组织基因结化会通过增加STAT1表达和神经炎症来加剧阿尔茨海默病 (AD) 的认知缺陷. 准这种表观遗传途径为AD提供了潜在的治疗策略.

科学领域:

神经科学是一个神经科学.
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
分子生物学分子生物学

背景情况:

阿尔茨海默病 (AD) 是一种主要的神经退行性疾病,其表观遗传基础尚未完全理解.
一种新的表观遗传修饰 (epigenetic modification) - - 基因组结,与神经炎症有关,但其在阿尔茨海默氏症相关认知衰退中的作用尚不清楚.

研究的目的:

为了调查基基化,特别是H3K18cr在阿尔茨海默氏病的发病和认知障碍中的作用.
探索涉及微质激活和STAT1信号的潜在分子机制.

主要方法:

在AD小鼠模型 (5xFAD,Aβ42注射) 和用克罗托尼酸治疗的野生类型小鼠中检查了基因组克罗托尼化水平.
评估认知功能,突触完整性,微质激活和H3K18cr局部化.
利用转录组分析,并通过特定的抑制剂验证了STAT1在微质细胞中的作用.

主要成果:

河马H3Kcr和H3K18cr在AD模型和克罗酸治疗小鼠中被上调,与认知缺陷和突触功能障碍相关.
克罗托尼酸诱导的微质分裂,H3K18cr在微质中特别升高.
转录组分析揭示了与免疫相关的途径,并突出了STAT1作为一个关键调节器,其激活由克罗酸是独立于JAK1的.

结论:

升高的微质H3K18cr是一种通过STAT1介导的神经炎症导致AD相关认知障碍的新型表观遗传贡献者.
微质中的H3K18cr-STAT1轴代表了阿尔茨海默病的潜在治疗标.

关键词:

美国国家统计局 (STAT1)克罗托尼酸是什么克罗托尼酸是什么组织基因子的克罗托尼化.微质细胞中的微质细胞神经炎症是一种神经炎症.

相关概念视频

01:22

Alzheimer's Disease: Treatment

976

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

976

02:32

Histone Modification

16.3K

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...

Histone Modification

Alzheimer's Disease: Overview

1.8K

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

1.8K

02:30

Histone Variants at the Centromere

5.1K

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...

5.1K

02:40

The Eukaryotic Promoter Region

19.0K

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...